The relevance of COVID-19 test kits varies across continents. Let’s compare thevirus checksin America to those in London.Public Health Englandstarted a strict program of contact tracing. The experts also tested potential cases. The program began in January. After all, this was the time when the outbreak first hit. The government,however, changed course. It insisted on checking. This was due to limited lab capacity. Besides, it’s also a result of a low supply of Coronavirus test kits. It insisted on this instead of focusing on increased ICU and ventilator capacity .Later, the need for further virus samples became clear. Thus, the U.K. labs had to compete with global shortages. Currently, Coronavirus monitoring is restricted to health-care staff. It also includes individuals with pneumonia signs and severe respiratory distress syndrome. Further, it, too, contains influenza-like disease victims.Other factors, as well, limited the widespread use of Covid-19 test kits. Firstly, testing involves a good public health laboratory system. Despite its efforts to raise range, it has narrowed its ability to scale and process results. It can’t do that at the same speed as other countries.Laboratories have been merged mainly in this country. Thus, we have a smaller number of more extensive labs. The alternative is to have a single sizeable test site. From my perspective, having a more critical test site or Test Centre Near is more efficient than dissipating our efforts into a lot of labs across the country.U.S. Facing Different Clinical Laboratory Testing ProblemsMeanwhile, some U.S. medical labs are now facing another problem. The issue involves unused testing capacity, Nature reported. For example, MIT and Harvard’s Broad Institute in Cambridge, Mass., can run up to 2,000 tests a day, “but we don’t do that many. Factors include shortages in supply. Others include incompatibility between hospital and electronic health record systems.Politico cited the narrow test criteria of the CDC. He also noted a lack of supplies to collect and analyze patient samples. They includeswabs and personal protective equipment. For him, they represent reasons for the slowdown in some clinical laboratories in the U.S.Challenges DeployingAntibody-based COVID-19 TestKits in the U.K.The United Kingdom also had issues deploying serology-based COVID-19 test kits. These kits intend to detect whether humans developed antibodies against the virus. Peacock added that they would distribute DIY Coronavirus test kits to the public. Distributors would use Amazon and retail pharmacy chains, the Independent reported. Furthermore, Politico said that the government had acquired more Home Test test kits.Researchers have a charge of validating the Home Test kits’ accuracy. They reported on April 5 that the Coronavirus checks had not performed well. They didn’t meet the criteria set by the U.K. Regulatory Agency for Medicines and Healthcare Products.We see many false negatives using virus testing kits. These represent screening where no antibody is detected, although we know there is one. Besides, we see false positives. Health authorities have acknowledged no test includes the necessary features. The features of these kits help to screen people for protective immunity.Meanwhile, the FDA released an Emergency Usage Authorization (EUA). The rule intended to regulate most COVID-19 test kits.